Gene · 10021
NIH grants1,074
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,074
Download this page as JSON| Grant | Title | HCN4 papers | Newest fiscal year |
|---|---|---|---|
| R01GM021342 | Energetics of Channel-Bilayer Interactions | 1 | 2021 |
| R01GM107462 | Atomic Level Analysis of Biomolecular Structure | 1 | 2021 |
| R01HL114120 | Endogenous and exogenous mechanisms that promote myocardial remuscularization in post infarction LV remodeling | 1 | 2021 |
| R01HL115148 | THE ROLE OF NOVEL AIP1 ISOFORM IN PATHOLOGICAL LYMPHANGIOGENESIS | 1 | 2021 |
| R01HL132073 | Etv1 is an Essential Regulator of Fast Conduction Tissues in the Heart | 1 | 2021 |
| R01HL134956 | Defining the spatio-temporal mechanisms of ventricular cell specification and differentiation | 1 | 2021 |
| R01HL135129 | Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome | 1 | 2021 |
| R01HL137710 | Complement Activation and Initiation of Heart Regeneration | 1 | 2021 |
| R01HL138466 | MACROPHAGE HETEROGENEITY IN HEART FAILURE PROGRESSION AND CARDIAC RECOVERY | 1 | 2021 |
| R01HL138486 | Molecular mechanisms underlying cardiac sodium channelopathy | 1 | 2021 |
| R01HL139714 | MACROPHAGE ONTOGENY SHIFTS IN ISCHEMIC HEART DISEASE | 1 | 2021 |
| R01HL141186 | Retinoic acid-dependent epigenetic and transcriptional mechanisms controlling heart development | 1 | 2021 |
| R01HL141570 | Perfusable 3D human cardiac constructs for heart regeneration | 1 | 2021 |
| R01HL141917 | Improving Mitral Compensation In Ischemic Regurgitation | 1 | 2021 |
| R01HL142498 | FHFs and Cardiac Electrophysiology | 1 | 2021 |
| R01HL142787 | Comprehensive Analysis of Allelic, Cellular and Molecular Heterogeneity in Human 3-Dimensional Cardiac Microtissues with MYH7 Mutations | 1 | 2021 |
| R01HL143485 | Fetal Electrophysiologic Abnormalities in High-risk Pregnancies Associated with Fetal Demise | 1 | 2021 |
| R01NS097147 | Pre-clinical testing of a novel immunotherapy for HTLV-induced neurologic disease | 1 | 2021 |
| R21ES030334 | Alternative splicing in arsenical skin carcinogenesis | 1 | 2021 |
| R21HG011964 | Epigenetic control and probabilistic disease programming | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10021/grants?page=19